FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

259858000: Varicella-zoster virus antibody (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
387004011 Varicella-zoster virus antibody en Synonym Active Entire term case sensitive SNOMED CT core module
651522011 Varicella-zoster virus antibody (substance) en Fully specified name Active Entire term case sensitive SNOMED CT core module
3005311010 Varicella-zoster virus immunoglobulin en Synonym Active Entire term case sensitive SNOMED CT core module
3288690017 Varicella immunoglobulin en Synonym Active Entire term case sensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Varicella-zoster virus antibody Is a Anti viral antibody true Inferred relationship Existential restriction modifier
Varicella-zoster virus antibody Causative agent Virus false Inferred relationship Existential restriction modifier
Varicella-zoster virus antibody Is a Immunoglobulin false Inferred relationship Existential restriction modifier
Varicella-zoster virus antibody Is a Vaccine, immunoglobulin, AND/OR antiserum false Inferred relationship Existential restriction modifier
Varicella-zoster virus antibody Is a Drug or medicament true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Measurement of Varicella-zoster virus antibody Component True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Varicella-zoster virus antibody immunoglobulin G measurement Component True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Varicella-zoster virus antibody immunoglobulin M measurement Component True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Varicella-zoster immunoglobulin adverse reaction Causative agent True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Allergy to Varicella-zoster virus antibody Causative agent False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Product containing Varicella-zoster virus antibody (medicinal product) Has active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Anti-varicella-zoster ig injection Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Varicella-zoster immune globulin 125 iu powder for injection solution vial Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Allergy to Varicella-zoster virus antibody Causative agent True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Varicella zoster virus immunoglobulin G antibody Is a True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Varicella-zoster antibody level Component True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Immunoglobulin M antibody to Varicella zoster virus Is a True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Varicella immunoglobulin Has active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 104 unit/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 104 unit/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) Has active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Product containing Varicella-zoster virus antibody in parenteral dose form (medicinal product form) Has active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Qualitative result of Varicella zoster virus total antibody in serum (observable entity) Component True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Qualitative result of Varicella zoster virus total antibody in cerebrospinal fluid (observable entity) Component True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier 1
Varicella immunoglobulin 250mg solution for injection vials (BPL (Bio Products laboratory)) Has active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Liberim Z 250mg solution for injection vials (Scottish National Blood Transfusion Service) Has active ingredient True Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Varicella immunoglobulin 250mg solution for injection vials 1 vial Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Varicella immunoglobulin 250mg solution for injection vials (BPL (Bio Products laboratory)) 1 vial Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier
Liberim Z 250mg solution for injection vials (Scottish National Blood Transfusion Service) 1 vial Has active ingredient False Varicella-zoster virus antibody Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start